Viewing Study NCT01862367


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-11 @ 4:07 AM
Study NCT ID: NCT01862367
Status: COMPLETED
Last Update Posted: 2019-07-09
First Post: 2013-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module